TREE NEWS update: China’s National Healthcare Security Administration will continue annual adjustments to the basic medical insurance drug list, aiming to include more innovative drugs for major diseases such as cancer, chronic conditions, rare diseases, and pediatric illnesses. The move seeks to unify reimbursement catalogs for medical services and consumables nationwide, reducing regional policy disparities.
China to Expand Reimbursement for Innovative Drugs
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
38m ago
China Raises Geological Disaster Response to Level III for Jiangxi
39m ago
Jiangxi Activates Level II Emergency Response for Geological Disaster in Suichuan
1h ago
Landslide in Jiangxi kills 1, leaves 11 missing
1h ago
First tunnel completed on China-Kyrgyzstan-Uzbekistan railway in Kyrgyzstan
2h ago
Abu Dhabi’s G42 in talks to sell majority stake to US firms for chip access
2h ago
Landslide in Jiangxi buries over a dozen people